Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™
October 21, 2020 08:30 ET
|
Zosano Pharma Corporation
--FDA feedback consistent with FDA’s preliminary communication in September----Company requesting meeting with FDA to discuss next steps required to resubmit the NDA-- FREMONT, Calif., Oct. 21, 2020...
Zosano Pharma Receives Preliminary FDA Communication on Qtrypta™ NDA
September 30, 2020 17:40 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company today announced that it has received a discipline review...
Zosano Pharma to Present at the Cantor Virtual Global Healthcare Conference
September 09, 2020 08:30 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive...
Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference
September 03, 2020 08:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive...
Zosano Announces Pricing of Public Offering of Common Stock
September 01, 2020 09:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public...
Zosano Pharma Announces Proposed Public Offering of Common Stock
August 31, 2020 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public...
Zosano Pharma Announces Agreement to Collaborate with Mitsubishi Tanabe Pharma Corporation
August 18, 2020 08:30 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a feasibility study...
Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™
August 06, 2020 17:00 ET
|
Zosano Pharma Corporation
Agreement outlines commercialization and distribution execution strategy upon FDA approval EVERSANA to provide commercial services of approximately $250 million over 5 years FREMONT, Calif.,...
Zosano Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update
August 06, 2020 08:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended...
Zosano Pharma to Present at the BTIG Biotechnology Conference 2020
August 03, 2020 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive...